World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 63 1809 1626 23 22 210 13323

Claudio J. Conti publications per year

The chart shows the history of publications by Claudio J. Conti between 1973 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Claudio J. Conti published across 51 years, from 1973 to 2023, averaging 5 papers a year. Output peaked at 18 publications in 1998. 13 of the 255 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1973 to 2023. Vertical axis: number of publications, 0 to 18. Peak 18 publications in 1998. 1973: 1 publication 1974: 1 publication 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 1 publication 1984: 1 publication 1985: 6 publications 1986: 7 publications 1987: 4 publications 1988: 5 publications 1989: 6 publications 1990: 7 publications 1991: 9 publications 1992: 8 publications 1993: 9 publications 1994: 8 publications 1995: 12 publications 1996: 11 publications 1997: 10 publications 1998: 18 publications 1999: 10 publications 2000: 8 publications 2001: 8 publications 2002: 13 publications 2003: 7 publications 2004: 14 publications 2005: 4 publications 2006: 2 publications 2007: 5 publications 2008: 5 publications 2009: 5 publications 2010: 3 publications 2011: 6 publications 2012: 5 publications 2013: 4 publications 2014: 3 publications 2015: 3 publications 2016: 2 publications 2017: 3 publications 2018: 0 publications 2019: 5 publications 2020: 3 publications 2021: 0 publications 2022: 1 publication 2023: 12 publications
1973 2023

255 publications in total across all disciplines

View publications per year as a table
Claudio J. Conti: publications per year, 1973 to 2023
Year Publications
1973 1
1974 1
1975 0
1976 0
1977 0
1978 0
1979 0
1980 0
1981 0
1982 0
1983 1
1984 1
1985 6
1986 7
1987 4
1988 5
1989 6
1990 7
1991 9
1992 8
1993 9
1994 8
1995 12
1996 11
1997 10
1998 18
1999 10
2000 8
2001 8
2002 13
2003 7
2004 14
2005 4
2006 2
2007 5
2008 5
2009 5
2010 3
2011 6
2012 5
2013 4
2014 3
2015 3
2016 2
2017 3
2018 0
2019 5
2020 3
2021 0
2022 1
2023 12
Total 255
Download as CSV

Claudio J. Conti publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Claudio J. Conti sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 207–216 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 210 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89 210
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Claudio J. Conti D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio J. Conti sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 62–63 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 63 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105 63
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

Claudio J. Conti is affiliated with Texas A&M University in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a focus on oncology, dermatology, immunology, physiology, and molecular biology. The scientist's work is reflected in a range of recent publications exploring topics relevant to cancer biology, skin diseases, and immune responses.

In recent years, Claudio J. Conti has contributed to papers covering diverse biomedical topics. Notable publications include:

  • The importance of immunity in the development of reliable animal models for psoriasis and atopic dermatitis, 2020, Immunology and Cell Biology
  • Early Dietary Exposures Epigenetically Program Mammary Cancer Susceptibility through Igf1-Mediated Expansion of the Mammary Stem Cell Compartment, 2022, Cells
  • Humanization of Tumor Stroma by Tissue Engineering as a Tool to Improve Squamous Cell Carcinoma Xenograft, 2020, International Journal of Molecular Sciences

The primary topics covered in these papers align with the scientist's broader research interests, which include:

  • Cancer Cells and Metastasis
  • Dermatology and Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Asthma and respiratory diseases
  • Epigenetics and DNA Methylation
  • Digestive system and related health
  • Tissue Engineering and Regenerative Medicine

Claudio J. Conti frequently publishes in journals such as Immunology and Cell Biology, Cells, and the International Journal of Molecular Sciences. These venues reflect the interdisciplinary nature of the scientist's research efforts, crossing immunology, molecular biology, and clinical medicine.

The scientist has collaborated with a number of co-authors on various projects. The most frequent collaborators include Sara Guerrero-Aspizua, Marcela Del Río, Marta Carretero, Yuanning Zheng, and Linjie Luo. These partnerships contribute to the multidisciplinary approach seen in their work.

Best Publications

  • Induction of cyclin D1 overexpression by activated ras.

    J. Filmus;A. I. Robles;Wen Shi;M. J. Wong

  • Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo

    Ana I. Robles;Marcelo L. Rodriguez-Puebla;Adam B. Glick;Carol Trempus

  • Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment

    David B. Klug;Carla Carter;Elizabeth Crouch;Dennis Roop

  • High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC

    Arthur T. Sands;Alejandro Abuin;Ana Sanchez;Claudio J. Conti

  • Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.

    R. Murillas;F. Larcher;C. J. Conti;M. Santos

  • Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.

    Panomwat Amornphimoltham;Virote Sriuranpong;Vyomesh Patel;Fernando Jose Benavides

  • Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development

    Angela M Pierce;Susan M Fisher;Claudio J Conti;David G Johnson

  • Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.

    B. Ruggeri;J. Caamano;T. Goodrow;M. DiRado

  • A Critical Role for ras-mediated, Epidermal Growth Factor Receptor-dependent Angiogenesis in Mouse Skin Carcinogenesis

    M. L. Casanova;F. Larcher;B. Casanova;R. Murillas

  • (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer

    Jean C. Zenklusen;Ivan Bieche;Rosette Lidereau;Claudio J. Conti

  • Overexpression of cyclin D1 in mouse skin carcinogenesis.

    Bianchi Ab;Fischer Sm;Robles Ai;Rinchik Em

  • Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors.

    A. B. Bianchi;C. M. Aldaz;C. J. Conti

  • The effect of vitamin E acetate on ultraviolet‐induced mouse skin carcinogenesis

    Thomas R. Berton;Thomas R. Berton;Claudio J. Conti;David L. Mitchell;C. Marcelo Aldaz

  • Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions.

    Claudio M Aldaz;David Trono;Fernando Larcher;Thomas J. Slaga

  • Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1

    Yian Chen;Luis A. Martinez;Margaret LaCava;Lezlee G Coghlan

  • Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance

    Jennifer D. Cook;Barbara J. Davis;Sheng-Li Cai;J. Carl Barrett

  • Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis

    Karla A. Lawson;Kristen Anderson;Marla Menchaca;Jeffrey Atkinson

  • p53 Mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential

    Nora M. Navone;Michael E. Labate;Patricia Troncoso;Louis L. Pisters

  • Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.

    Paula L. Miliani de Marval;Everardo Macias;Robert Rounbehler;Piotr Sicinski

  • Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31.

    Jean C. Zenklusen;Claudio J. Conti;Eric D. Green

Frequent Co-Authors

Thomas J. Slaga
Thomas J. Slaga The University of Texas Health Science Center at San Antonio
John DiGiovanni
John DiGiovanni The University of Texas at Austin
Andres J. P. Klein-Szanto
Andres J. P. Klein-Szanto Fox Chase Cancer Center
Dennis A. Johnston
Dennis A. Johnston Baylor University
Stephen D. Hursting
Stephen D. Hursting University of North Carolina at Chapel Hill
Cheryl L. Walker
Cheryl L. Walker Baylor College of Medicine
Andrew C. von Eschenbach
Andrew C. von Eschenbach United States Food and Drug Administration
Dennis R. Roop
Dennis R. Roop University of Colorado Anschutz Medical Campus
Giovanna Zambruno
Giovanna Zambruno Bambino Gesù Children's Hospital
Joaquín Dopazo
Joaquín Dopazo Institute of Biomedicine of Seville

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology opens doors to several exciting fields, many of which now offer flexible, online degree options. For those interested in healthcare communication, asha certified slp programs provide a direct path to becoming a speech-language pathologist, ensuring both quality education and career readiness.

Students without a background in speech pathology can consider enrolling in speech pathology bridge programs. These online courses make it easier for career changers or non-traditional students to enter this growing profession.

For those looking to enter nursing without prior experience, look into accelerated nursing programs for non nurses. These fast-track BSN options open many opportunities in healthcare, blending science with patient care.

Molecular biology majors may also pursue advanced nursing and focus on mental health. The outlook for psychiatric nurse practitioners is promising, and salaries are competitive across the U.S. To learn more, visit psychiatric nurse practitioner salary by state for state-specific data on this rewarding career.

Best Scientists Citing Claudio J. Conti

Trending Scientists

Recently Published Articles